Abstracts are now being accepted for presentation at the 13th PACTRIMS Congress in Singapore from 11-14 November, 2020. This year’s meeting provides an excellent froum for attendees to showcase their work, conveying interesting, innovative, clinically relevant information that enhances the professional skills of fellow MS professionals. Submission areas include:
Completed original research on pharmacologic agents, therapeutic issues and innovative services or outcomes of service provided to the MS patient population.
These posters represent currently ongoing, uncompleted studies. The author may discuss preliminary results of the studies, provided the research methods have been validated. Topics may include clinical drug studies, therapeutic issues, innovative services and outcomes.
An evidence-based treatment and management of a patient from the author’s clinical practice with an uncommon presentation and/or clinically challenging scenario, emphasising steps taken to maximise the likelihood of an optimal outcome.
These posters represent findings that have been presented at other meetings but contain information of interest to clinicians who care for MS patients. These completed studies need to be original research on pharmacologic issues, therapeutic considerations, innovative services or outcomes related to MS.